ERBB2 and breast cancer: In this study, we investigated the clinicopathological features of HER2 low expression based on male breast cancer population, and also focused on the expression of HER2 ultra-low in male breast cancer, and the results showed that the incidence of HER2 low expression was significantly higher in male breast cancer than in female breast cancer.